MENU
Aim higher

SIAGEN-MS

Sialylated antigens as immune tolerance inducers: an innovative therapeutic vaccine for MS.

Start date: 
01-01-2015
Project Duration: 
41months
Technological Area: 
Cellular and Molecular Biology
Market Area: 
Therapeutic services